ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
2 announcements with these filters
Rossari Biotech Ltd reported revenue from operations of ₹684.9 Cr (+18.2% YoY) and net profit of ₹46 Cr (+33.7% YoY) for Q4 FY26.
Rossari Biotech reported consolidated total income of ₹2,418.74 Crore for FY26. The Board recommended a final dividend of ₹0.50 per share (25%) and appointed Mr. Udeypaul Singh Gill as an Independent Director. Additionally, the company approved a new R&D facility in Navi Mumbai and an update on its capacity expansion project.